ENGAGE XR (EXR) Competitors GBX 0.90 -0.10 (-9.80%) As of 08:29 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsBuy This Stock EXR vs. AKR, PEB, TPG, APPS, AMP, MTR, CPT, CYS, WINV, and EARNShould you be buying ENGAGE XR stock or one of its competitors? The main competitors of ENGAGE XR include Akers Biosciences (AKR), Pebble Beach Systems Group (PEB), TP Group (TPG), Appscatter Group (APPS), Amphion Innovations (AMP), Metal Tiger (MTR), Concepta PLC (CPT.L) (CPT), Chrysalis VCT (CYS), Worsley Investors (WINV), and EARNZ (EARN). These companies are all part of the "trading" industry. ENGAGE XR vs. Its Competitors Akers Biosciences Pebble Beach Systems Group TP Group Appscatter Group Amphion Innovations Metal Tiger Concepta PLC (CPT.L) Chrysalis VCT Worsley Investors EARNZ ENGAGE XR (LON:EXR) and Akers Biosciences (LON:AKR) are both small-cap trading companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, media sentiment, valuation, institutional ownership, risk, profitability, analyst recommendations and dividends. Is EXR or AKR more profitable? Akers Biosciences has a net margin of 0.00% compared to ENGAGE XR's net margin of -115.52%. Akers Biosciences' return on equity of 0.00% beat ENGAGE XR's return on equity.Company Net Margins Return on Equity Return on Assets ENGAGE XR-115.52% -21.89% -26.98% Akers Biosciences N/A N/A N/A Do insiders & institutionals hold more shares of EXR or AKR? 15.9% of ENGAGE XR shares are owned by institutional investors. 15.4% of ENGAGE XR shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Does the media prefer EXR or AKR? In the previous week, ENGAGE XR's average media sentiment score of 0.00 equaled Akers Biosciences'average media sentiment score. Company Overall Sentiment ENGAGE XR Neutral Akers Biosciences Neutral Which has stronger valuation & earnings, EXR or AKR? Akers Biosciences has lower revenue, but higher earnings than ENGAGE XR. ENGAGE XR is trading at a lower price-to-earnings ratio than Akers Biosciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioENGAGE XR£3.40M1.39-£2.38M-£0.01-112.75Akers Biosciences£2.32M0.00N/A-£129.60N/A SummaryENGAGE XR and Akers Biosciences tied by winning 4 of the 8 factors compared between the two stocks. Get ENGAGE XR News Delivered to You Automatically Sign up to receive the latest news and ratings for EXR and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart EXR vs. The Competition Export to ExcelMetricENGAGE XRSoftware IndustryComputer SectorLON ExchangeMarket Cap£4.73M£7.14B£32.22B£2.63BDividend YieldN/A3.74%3.17%5.32%P/E Ratio-112.751,252.93454.105,393.63Price / Sales1.39251.131,764.5098,564.61Price / CashN/A17.2937.6227.92Price / Book0.5510.707.228.34Net Income-£2.38M£49.83M£809.16M£5.89B7 Day Performance-11.13%-1.55%-0.63%15.12%1 Month Performance-16.48%0.65%6.32%2.47%1 Year Performance0.22%6.07%24,153.35%160.28% ENGAGE XR Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)EXRENGAGE XRN/AGBX 0.90-9.8%N/A+28.2%£4.73M£3.40M-112.754,780Gap DownAKRAkers BiosciencesN/AN/AN/AN/A£21.64M£2.32M-0.44120PEBPebble Beach Systems GroupN/AGBX 16.53-2.8%N/A+61.1%£21.16M£12.10M-1,836.1160High Trading VolumeTPGTP GroupN/AN/AN/AN/A£17.14M£45.09M-2.201,110High Trading VolumeAPPSAppscatter GroupN/AN/AN/AN/A£16.74M£758.10K-1.25840AMPAmphion InnovationsN/AGBX 2.26-2.0%N/A+1,546.7%£16.62M£14.37M-75.1713,500Gap DownMTRMetal TigerN/AN/AN/AN/A£15.35M-£5.90M-226.508Gap UpHigh Trading VolumeCPTConcepta PLC (CPT.L)N/AN/AN/AN/A£10.25M£28.96K-2.831,650Gap UpHigh Trading VolumeCYSChrysalis VCTN/AN/AN/AN/A£9.25M£789K65.0017WINVWorsley InvestorsN/AGBX 28+9.8%N/A-11.6%£8.60M-£1.66M-336.132Gap UpEARNEARNZN/AGBX 6.05+5.2%N/A-22.4%£6.90M£2.64M-13,152.1711High Trading Volume Related Companies and Tools Related Companies AKR Alternatives PEB Alternatives TPG Alternatives APPS Alternatives AMP Alternatives MTR Alternatives CPT Alternatives CYS Alternatives WINV Alternatives EARN Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:EXR) was last updated on 9/26/2025 by MarketBeat.com Staff From Our PartnersYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | Sponsored6-Figure Target for BTC by 2025Crypto ETF records broken – here's what’s next The biggest names in finance have built the infrastructure f...Crypto 101 Media | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | SponsoredNew Buy Alert: Should you put $1,000 into Oracle (ORCL) now?Barron's is calling this Oracle's "Nvidia Moment..." While the Wall Street Journal is simply calling Oracle...Chaikin Analytics | SponsoredWhy More Investors Are Using Family Trusts to Protect Their WealthFor many investors, a family trust can be an essential tool for protecting assets, avoiding probate, and ensur...SmartAsset | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ENGAGE XR Holdings plc Please log in to your account or sign up in order to add this asset to your watchlist. Share ENGAGE XR With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.